ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Does the Adjuvant Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Change the Natural History of Resected EGFR Mutation-Positive Non-Small Cell Lung Cancer? Is it for Prime Time?
SSRN Electronic Journal
◽
10.2139/ssrn.3967074
◽
2021
◽
Author(s):
Hyun Ae Jung
◽
Jinyeong Lim
◽
Se-Hoon Lee
◽
Je-Gun Joung
◽
Yeong Jeong Jeon
◽
...
Keyword(s):
Lung Cancer
◽
Egfr Mutation
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Small Cell
◽
Prime Time
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
History Of
◽
Epidermal Growth
Download Full-text
Related Documents
Cited By
References
Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
The Korean Journal of Internal Medicine
◽
10.3904/kjim.2016.190
◽
2017
◽
Vol 32
(3)
◽
pp. 422-428
◽
Cited By ~ 1
Author(s):
Yong Won Choi
◽
Jin-Hyuk Choi
Keyword(s):
Lung Cancer
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Egfr Mutation
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Small Cell
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Epidermal Growth
Download Full-text
481TiP Checkmate 722: A phase 3 trial of nivolumab with chemotherapy or ipilimumab vs chemotherapy in epidermal growth factor receptor (EGFR)-mutation, T790M-negative stage IV or recurrent non-small cell lung cancer (NSCLC) after EGFR tyrosine kinase inhibitor (TKI) therapy
Annals of Oncology
◽
10.1093/annonc/mdw594.045
◽
2016
◽
Vol 27
(suppl_9)
◽
Cited By ~ 2
Author(s):
K. Nakagawa
◽
J.C-H. Yang
◽
K. Park
◽
Y. Ohe
◽
Y-L. Wu
◽
...
Keyword(s):
Lung Cancer
◽
Egfr Mutation
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Phase 3
◽
Epidermal Growth
Download Full-text
Neutrophil to lymphocyte ratio (NLR) as a predictive marker of response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in EGFR mutation-positive non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.e19117
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. e19117-e19117
Author(s):
Gayatri Vaidyanathan
◽
Grace K. Dy
◽
Petr Starostik
◽
Shiva Dibaj
Keyword(s):
Lung Cancer
◽
Epidermal Growth Factor Receptor
◽
Egfr Mutation
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Predictive Marker
◽
Small Cell
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Epidermal Growth
Download Full-text
481TiP Checkmate 722: A phase 3 trial of nivolumab with chemotherapy or ipilimumab vs chemotherapy in epidermal growth factor receptor (EGFR)-mutation, T790M-negative stage IV or recurrent non-small cell lung cancer (NSCLC) after EGFR tyrosine kinase inhibitor (TKI) therapy
Annals of Oncology
◽
10.1016/s0923-7534(21)00639-6
◽
2016
◽
Vol 27
◽
pp. ix154-ix155
Author(s):
K. Nakagawa
◽
J.C.-H. Yang
◽
K. Park
◽
Y. Ohe
◽
Y.-L. Wu
◽
...
Keyword(s):
Lung Cancer
◽
Egfr Mutation
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Phase 3
◽
Epidermal Growth
Download Full-text
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations
Investigational New Drugs
◽
10.1007/s10637-019-00732-4
◽
2019
◽
Vol 37
(6)
◽
pp. 1207-1217
Author(s):
Makoto Nishio
◽
Haruyasu Murakami
◽
Yuichiro Ohe
◽
Toyoaki Hida
◽
Hiroshi Sakai
◽
...
Keyword(s):
Lung Cancer
◽
Phase I Study
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Small Cell
◽
Egfr Mutations
◽
Third Generation
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Epidermal Growth
Download Full-text
Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease
Journal of Thoracic Oncology
◽
10.1097/jto.0000000000000380
◽
2015
◽
Vol 10
(1)
◽
pp. 156-163
◽
Cited By ~ 150
Author(s):
Petra Hoffknecht
◽
Amanda Tufman
◽
Thomas Wehler
◽
Theo Pelzer
◽
Rainer Wiewrodt
◽
...
Keyword(s):
Lung Cancer
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Small Cell
◽
Leptomeningeal Disease
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Lung Cancer Patients
◽
Erbb Family Blocker
◽
Epidermal Growth
Download Full-text
Clinical Significance of Sequential Treatment with Afatinib in the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment of Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3935
◽
2019
◽
Author(s):
N. Kobayashi
◽
H. Aiko
◽
C. Kamimaki
◽
N. Mikami
◽
S. Kubo
◽
...
Keyword(s):
Lung Cancer
◽
Epidermal Growth Factor Receptor
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Small Cell
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Epidermal Growth
◽
Tki Treatment
◽
Egfr Mutant
Download Full-text
Pneumonitis in advanced non-small-cell lung cancer (NSCLC) patients (pts) treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI): Meta-analysis of 153 trial cohorts with 15,713 pts.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.e21223
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. e21223-e21223
Author(s):
Chong Hyun Suh
◽
Hyesun Park
◽
Kyung Won Kim
◽
Junhee Pyo
◽
Hiroto Hatabu
◽
...
Keyword(s):
Lung Cancer
◽
Epidermal Growth Factor Receptor
◽
Kinase Inhibitor
◽
Meta Analysis
◽
Growth Factor Receptor
◽
Small Cell
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Epidermal Growth
◽
Nsclc Patients
Download Full-text
Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation
Journal of Thoracic Oncology
◽
10.1097/jto.0b013e31828c3929
◽
2013
◽
Vol 8
(7)
◽
pp. 892-898
◽
Cited By ~ 24
Author(s):
Kosuke Tanaka
◽
Akito Hata
◽
Reiko Kaji
◽
Shiro Fujita
◽
Takehiro Otoshi
◽
...
Keyword(s):
Lung Cancer
◽
Receptor Tyrosine Kinase
◽
Egfr Mutation
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Small Cell
◽
Cytokeratin 19
◽
Small Cell Lung
◽
Epidermal Growth
◽
Cytokeratin 19 Fragment
Download Full-text
Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial)
Japanese Journal of Clinical Oncology
◽
10.1093/jjco/hyz023
◽
2019
◽
Vol 49
(6)
◽
pp. 554-558
◽
Cited By ~ 5
Author(s):
Kazuhiro Usui
◽
Takuma Yokoyama
◽
Go Naka
◽
Hiroo Ishida
◽
Kazuma Kishi
◽
...
Keyword(s):
Lung Cancer
◽
Epidermal Growth Factor Receptor
◽
Kinase Inhibitor
◽
Growth Factor Receptor
◽
Small Cell
◽
Small Cell Lung
◽
Egfr Tyrosine Kinase Inhibitor
◽
Epidermal Growth
◽
Egfr Mutant
◽
Inhibitor Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close